BRIEF

on SPINEGUARD (EPA:ALSGD)

SpineGuard obtains European validation for its patent in orthopedic surgery

Stock price chart of SPINEGUARD (EPA:ALSGD) showing fluctuations.

SpineGuard, a company specializing in digital surgical guidance, announced that the European Patent Office has validated its patent for automatic bone gap detection. This patent protects algorithms used during bone drilling operations, designed to make orthopedic procedures safer and simpler.

Stéphane Bette, Deputy CEO of SpineGuard, emphasizes the importance of this patent, which strengthens strategic discussions with the industry, particularly for applications in motorized and robotic equipment. SpineGuard, with a robust intellectual property portfolio of 72 patents, continues to expand its DSG technology to smart surgical tools.

Developed in partnership with research institutes such as the CNRS, this patent marks an important step for the company, which already has a previous validation in the United States. SpineGuard hopes to confirm its position in the international market for advanced medical technologies.

R. P.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SPINEGUARD news